The importance of
hypoxia in the pathophysiology of
inflammatory bowel disease (IBD) is increasingly being realized; also,
hypoxia seems to be an important accelerator of
brain inflammation, as has been reported by our group and others. IBD is a chronic intestinal disorder that leads to the development of
inflammation, which is related to brain dysfunction. However, no studies have reported whether
hypoxia is associated with IBD-induced
neuroinflammation. Therefore, the objective of the present study was to determine whether
hypoxia augments cerebral
inflammation in a DSS-induced
colitis mouse model. The mouse model was developed using 3% DSS for five days combined with exposure to hypoxic conditions (6,000 m) for two days. Mice were randomly divided into four groups: control group, DSS group,
hypoxia group, and DSS plus
hypoxia group. The results demonstrated that DSS combined with
hypoxia resulted in up-regulation of colonic and plasmatic proinflammatory
cytokines. Meanwhile, DSS plus
hypoxia increased expression of Iba1, which is a marker of activated microglia, accompanied by increased expression of
tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and
interleukin-6 (IL-6) in the brain. Moreover, the expression of
tight junction proteins, such as zonula occludens-1 (ZO-1),
occludin, and
claudin-5, was markedly downregulated. The current study provides new insight into how
hypoxia exposure induces excessive inflammatory responses andpathophysiological consequences in the brain in a DSS-induced
colitis model.